Sydney Vital Flagship Program 1 is currently looking to hire a Research Fellow.
Dr Andrew Care has been a member of Sydney Vital since 2017 and this year was awarded a 2018 Early Career Fellowship from the Cancer Institute NSW.
Applications are invited from suitably qualified researchers for a Research Fellowship under Sydney Vital Flagship Program 3: Nanotechnology.
This is also to invite any of you interested in Translational Cancer Research to become a member of Sydney Vital.
Call for Applications: Tuesday 31st January 2017
Closing Date for Applications: Tuesday 27th February 2017
Announcement of Outcome aim at: Wednesday 15th March 2017
Please let us know if you have any further questions.
Email: Sydneyvital.firstname.lastname@example.org for general information regarding your application submission.
Email: Alexander Engel: Alexander.Engel@Sydney.edu.au for specific question regarding the Flagship 3.
Sydney Vital is pleased to offer 5 x Research Scholarship Awards to the value of $10,000 each for one year, to students, preclinical and clinical researchers working in the area of Translational Cancer Research.
The research projects below were awarded by Sydney Vital. We will post their progress when it is submitted and to keep up-to-date with our scholarships, funding and awards, check out our grant schemes.
|1||Jerikho Bulanadi||Kolling Institute of Medical Research||Prof Ross Smith||Chemotherapeutic prodrugs incorporated within recombinant high density lipoprotein nanoparticles as a modality of targeted delivery.||$15,000|
|2||Emma Colvill||Sydney University Medical School||Prof Paul Keall||The bench-to-bedside clinical implementation of real-time targeted radiotherapy for prostate cancer||$15,000|
|3||Grace Gifford||Haematology and Anatomical Pathology Departments. Royal North Shore Hospital, St Leonards, Sydney||Dr William Stevenson||Gene expression profiling of high grade B-cell lymphomas with NanoString nCounter technology. Validation of a novel diagnostic platform and implementation into clinical use for prognostication and therapeutic decision-making.||$15,000|
|4||Dr Anthony Glover||Kolling Institute of Medical Research, Royal North Shore Hospital||Prof Stanley Sidhu||Noncoding RNAs as tumour suppressors in adrenal cancer: Unlocking the mechanisms to improve patient outcomes.||$15,000|
|5||Diana Hatoum||Faculty of Science, UTS Sydney||Dr Najah Nassif||A Role for p14ARF-p53 in Treatment Resistance and Recurrence in Hormone-dependent Breast Cancer.||$15,000|
|6||Samuel Brennan||Faculty of Science, UTS Sydney||Dr Rose Martiniello-Wilks||Development of a non-invasive liquid biopsy for prostate cancer: Identification of unique exosome microRNA (exomiR) signatures in patient body fluids for cancer diagnosis and prognosis.||$15,000|
|7||Ben Harris||Sydney Medical School, University of Sydney||Dr Kellie Charles||Investigating mechanisms of chemoresistance to platinum drugs mediated by systemic inflammation.||$15,000|
|8||Adrian Lee||Bill Walsh Translation Cancer Research Laboratory, Kolling Institute||Dr Viive Howell||"Do molecular aberrations in the tumour predict for venous thrombotic episodes in patients with|
|9||Jaynish Shah||Sydney Medical School, University of Sydney||Prof Deborah Marsh||Investigating the complexity of p53 pathways in ovarian cancer: are non-coding RNAs the key?||$15,000|
Sydney Vital is pleased to offer 5 x Research Scholarship Awards to the value of $15,000 each for one year to students, preclinical and clinical researchers working in the area of Translational Cancer Research. These awards are to be used to support the research and are to be spent at the discretion of the student and their supervisor(s).
Key Dates for Round 3
Call for Applications: 1 September 2015
Closing Date for Applications: 1 October 2015
Announcement of Outcome: 1 November 2015
CALL FOR EOI’S
Sydney Vital is calling for proposals for implementation research pilot projects via an Expression of Interests (EOI) process.
Sydney Vital will provide financial support for a number of implementation research projects in the 2015 calendar year.
This expression of interest (EOI) may include (but are not limited to) the following themes:
• Educate Sydney Vital member network on implementation (T3) of evidence based supportive care strategies for cancer symptoms and treatment side effects.
• Develop Health Professional Education modules using e-learning techniques which can be made available to clinicians in NSW.
• Identify new clinical pathways or techniques based on the evidence based guidelines suitable for implementation
• Test methods for delivery of psychosocial support and reduction of treatment toxicity
• Evaluating new approaches to breast reconstruction and their impact on Quality of Life (QoL).
• Identify ways to improve management of survivorship issues in cancer patients.
• Test new methods of care or prognostic factors for patients with late stage cancer.
Up to $25,000 in funding to support the undertaking of an implementation research project. The funding must be spent within 12 months of receiving the award. Management team may allocate funding to one or more projects.
Read More: Implementation Research_Seed Funding 2015_EOI
Closing Date for EOI’s: Friday, 5 June 2015